State NV
Clinical Trials in Nevada
Nevada is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Nevada and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 91 actively recruiting studies with Nevada sites out of 91 registered in total. The busiest research areas in Nevada are Breast Cancer, Ovarian Neoplasms, Metastatic Breast Cancer. Leading sponsors running trials in the state include National Cancer Institute (NCI), AstraZeneca, Eli Lilly and Company. By stage, Nevada trials break down as Phase 1 (7), Phase 2 (26), Phase 3 (42), Phase 4 (2).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Nevada
Frequently Asked Questions — Clinical Trials in Nevada
How many clinical trials are currently recruiting in Nevada?
ClinicalMetric currently tracks 91 actively recruiting clinical trials with at least one location in Nevada. The total number of registered studies—including active but not currently enrolling trials—is 91. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Nevada?
Nevada hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Ovarian Neoplasms, Metastatic Breast Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Nevada serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Nevada?
To join a clinical trial in Nevada, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Nevada maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Nevada
NCT04322318 Phase 2
Recruiting
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and R...
Condition
Anaplastic Kidney Wilms Tumor
Enrollment
256 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT06797518 Phase 2
Recruiting
Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kid...
Condition
Glomerulonephritis, IGA
Enrollment
20 pts
Location
United States, Argentina, Israel
Sponsor
Novartis Pharmaceuticals
NCT06290128 Phase 3
Recruiting
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inf...
Condition
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Enrollment
140 pts
Location
United States, Argentina, Belgium
Sponsor
Sanofi
NCT00231400 N/A
Recruiting
Pompe Disease Registry Protocol
Condition
Glycogen Storage Disease Type II
Enrollment
2,000 pts
Location
United States, Argentina, Australia
Sponsor
Genzyme, a Sanofi Company
NCT06997497 Phase 3
Recruiting
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy ...
Condition
Colon Adenocarcinoma
Enrollment
477 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT05304767 Phase 3
Recruiting
An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive Kar...
Condition
Schizophrenia
Enrollment
280 pts
Location
United States, Bulgaria, Czechia
Sponsor
Karuna Therapeutics, Inc., a B
NCT06962839 Phase 2
Recruiting
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Dia...
Condition
Macular Edema
Enrollment
300 pts
Location
United States, China, Czechia
Sponsor
Boehringer Ingelheim
NCT06690398 Phase 3
Recruiting
Multicenter Study of Lumateperone for the Treatment of Irritability Associated W...
Condition
Irritability Associated With Autism Spectrum Disorder
Enrollment
160 pts
Location
United States
Sponsor
Intra-Cellular Therapies, Inc.
NCT07288398 Phase 3
Recruiting
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Condition
Pulmonary Hypertension Associated With HFpEF
Enrollment
540 pts
Location
United States, Argentina, Austria
Sponsor
Tenax Therapeutics, Inc.
NCT07321886 Phase 3
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight ...
Condition
Obesity
Enrollment
1,980 pts
Location
United States, Argentina, Australia
Sponsor
Eli Lilly and Company
NCT06605183 N/A
Recruiting
10,000 Step Club: Community Walking Program for People with Parkinson's Disease
Condition
Parkinson Disease
Enrollment
60 pts
Location
United States
Sponsor
University of Nevada, Las Vega
NCT06988605 N/A
Recruiting
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe A...
Condition
Atopic Dermatitis
Enrollment
1,000 pts
Location
United States, Germany, United Kingdom
Sponsor
Galderma R&D
NCT07610837 Phase 2
Recruiting
Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steat...
Condition
Liver Fibrosis
Enrollment
104 pts
Location
United States
Sponsor
AstraZeneca
NCT06058377 Phase 3
Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy T...
Condition
Anatomic Stage II Breast Cancer AJCC v8
Enrollment
3,680 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT04267848 Phase 3
Recruiting
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemoth...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
1,210 pts
Location
United States, Guam
Sponsor
National Cancer Institute (NCI
NCT03851445 Phase 2, Phase 3
Recruiting
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung...
Condition
Previously Treated Non-Small Cell Lung Cancer
Enrollment
10,000 pts
Location
United States
Sponsor
SWOG Cancer Research Network
Page 4 of 4 — 91 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology